Pharmacogenomics: novel loci identification via integrating gene differential analysis and eQTL analysis.

Nearly one-half of asthmatic patients do not respond to the most commonly prescribed controller therapy, inhaled corticosteroids (ICS). We conducted an expression quantitative trait loci (eQTL) analysis using >300 expression microarrays (from 117 lymphoblastoid cell lines) in corticosteroid (dexamethasone) treated and untreated cells derived from asthmatic subjects in the Childhood Asthma Management Program (CAMP) clinical trial. We then tested the associations of eQTL with longitudinal change in airway responsiveness to methacholine (LnPC20) on ICS. We identified 2484 cis-eQTL affecting 767 genes following dexamethasone treatment. A significant over-representation of lnPC20-associated cis-eQTL [190 single-nucleotide polymorphisms (SNPs)] among differentially expressed genes (odds ratio = 1.76, 95% confidence interval: 1.35-2.29) was noted in CAMP Caucasians. Forty-six of these 190 clinical associations were replicated in CAMP African Americans, including seven SNPs near six genes meeting criteria for genome-wide significance (P < 2 × 10(-7)). Notably, the majority of genome-wide findings would not have been uncovered via analysis of untreated samples. These results indicate that identifying eQTL after relevant environmental perturbation enables identification of true pharmacogenetic variants.

[1]  E. Silverman,et al.  Heterogeneity of therapeutic responses in asthma. , 2000, British medical bulletin.

[2]  D S Pearlman,et al.  Pathophysiology of the inflammatory response. , 1999, The Journal of allergy and clinical immunology.

[3]  Yusuke Nakamura,et al.  Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. , 2011, The New England journal of medicine.

[4]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[5]  Brigit VanGraafeiland,et al.  National Asthma Education and Prevention Program. , 2002, The Nurse practitioner.

[6]  M. Sears,et al.  Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. , 1991, The New England journal of medicine.

[7]  R. Wu,et al.  Genome-wide Association Identifies the T Gene as a Novel Asthma Pharmacogenetic Locus at a Glance Commentary , 2022 .

[8]  S. Gabriel,et al.  Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. , 2004, Human molecular genetics.

[9]  P. Frith,et al.  Reproducibility and comparison of responses to inhaled histamine and methacholine. , 1978, Thorax.

[10]  Wei Chen,et al.  Gene Expression in Skin and Lymphoblastoid Cells: Refined Statistical Method Reveals Extensive Overlap in Cis-eqtl Signals , 2022 .

[11]  E. Israel,et al.  Treatment of asthma with drugs modifying the leukotriene pathway. , 1999, The New England journal of medicine.

[12]  R. Geha,et al.  IgE in asthma and atopy: cellular and molecular connections. , 1999, The Journal of clinical investigation.

[13]  D. Umetsu,et al.  Critical role of B cells in the development of T cell tolerance to aeroallergens. , 2002, International immunology.

[14]  Gary D. Bader,et al.  The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function , 2010, Nucleic Acids Res..

[15]  Heather Eliassen,et al.  The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group. , 1999, Controlled clinical trials.

[16]  R. Geha,et al.  The regulation of immunoglobulin E class-switch recombination , 2003, Nature Reviews Immunology.

[17]  J. Xu,et al.  FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma. , 2007, The Journal of allergy and clinical immunology.

[18]  A. Riutta,et al.  Opposite effects of nicotinic acid and pyridoxine on systemic prostacyclin, thromboxane and leukotriene production in man. , 2002, Pharmacology & toxicology.

[19]  S. Weiss,et al.  TBX21: A functional variant predicts improvement in asthma with the use of inhaled corticosteroids , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  F. Hargreave,et al.  Bronchial reactivity to inhaled histamine: a method and clinical survey , 1977, Clinical allergy.

[21]  Ingo Ruczinski,et al.  Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. , 2009, American journal of human genetics.

[22]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[23]  Vivian G. Cheung,et al.  Genetic analysis of radiation-induced changes in human gene expression , 2009, Nature.

[24]  N Franklin Adkinson,et al.  Long-term effects of budesonide or nedocromil in children with asthma. , 2000, The New England journal of medicine.

[25]  Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. , 2007, The Journal of allergy and clinical immunology.

[26]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[27]  Christopher D. Brown,et al.  A statin-dependent QTL for GATM expression is associated with statin-induced myopathy , 2013, Nature.

[28]  Third Expert Panel on theDiagnosis,et al.  Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma , 1997 .

[29]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[30]  M. Yacoub,et al.  Activation of Peroxisome Proliferator-Activated Receptors in Human Airway Smooth Muscle Cells Has a Superior Anti-inflammatory Profile to Corticosteroids: Relevance for Chronic Obstructive Pulmonary Disease Therapy 1 , 2003, The Journal of Immunology.

[31]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[32]  Gonçalo R. Abecasis,et al.  Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma , 2007, Nature.

[33]  Matthew Stephens,et al.  Interactions between Glucocorticoid Treatment and Cis-Regulatory Polymorphisms Contribute to Cellular Response Phenotypes , 2011, PLoS genetics.

[34]  Scott T. Weiss,et al.  Global Analysis of the Impact of Environmental Perturbation on cis-Regulation of Gene Expression , 2011, PLoS genetics.

[35]  Robert Gentleman,et al.  GGtools: analysis of genetics of gene expression in bioconductor , 2007, Bioinform..

[36]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.